Publications: Ms Hayley Edwards von Velt Holt
Holt H, Jolliffe DA, Talaei M, Faustini S, Vivaldi G, Greenig M, Richter AG, Lyons RA et al.
(
2023
)
.
Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination
.
NPJ Vaccines
vol.
8
,
(
1
)
Talaei M, Faustini S, Holt H, Jolliffe DA, Vivaldi G, Greenig M, Perdek N, Maltby S et al.
(
2022
)
.
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
.
BMC Medicine
vol.
20
,
(
1
)
Vivaldi G, Jolliffe D, Tydeman F, Talaei M, Davies GA, Lyons RA, GRIFFITHS CJ, Kee F et al.
(
2022
)
.
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT1262b2 and after booster vaccination with BNT1262b2 or mRNA-1273: a population-based cohort study (COVIDENCE UK)
.
The Lancet Regional Health Europe
Holt H, Talaei M, Greenig M, Zenner D, Symons J, Relton C, Young KS, Davies MR et al.
(
2022
)
.
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)
.
Thorax
vol.
77
,
(
9
)
900
-
912
.
Holt H, Talaei M, Greenig M, Zenner D, Symons J, Relton C, Young K, Davies M et al.
(
2021
)
.
Risk Factors for Developing COVID-19: A Population-Based Longitudinal Study (COVIDENCE UK)
.
Thorax
Holt H, Martineau A, Greenig M, Talaei M, Rajpoot S, Kayyale A, Rifai SE, Lloyd P et al.
(
2021
)
.
S2 Vigorous exercise is protective against COVID-19: cross-sectional analysis of baseline data from 9,817 UK adults participating in the COVIDENCE UK study
.
Thorax
.
Conference:
Predicting and stratifying COVID-19 using real world data
vol.
76
,
a4
-
a4
.